Maud L, Barakat N, Bornot J, Snini S, Mathieu F
J Fungi (Basel). 2025; 11(1).
PMID: 39852424
PMC: 11766079.
DOI: 10.3390/jof11010004.
Kaewkhao N, Hanpithakpong W, Tarning J, Blessborn D
Wellcome Open Res. 2024; 9:231.
PMID: 39355658
PMC: 11443190.
DOI: 10.12688/wellcomeopenres.20613.2.
Mi Y, Guo Y, Luo X, Bai Y, Chen H, Wang M
Pathog Dis. 2024; 82.
PMID: 39317665
PMC: 11556344.
DOI: 10.1093/femspd/ftae022.
Rahman M, Morshed M, Adnan S, Howlader M
Heliyon. 2024; 10(11):e31453.
PMID: 38832263
PMC: 11145214.
DOI: 10.1016/j.heliyon.2024.e31453.
Cramer E, Nguyen X, Hertz J, Nguyen D, Quang H, Mendenhall I
PLoS Negl Trop Dis. 2024; 18(4):e0012014.
PMID: 38683855
PMC: 11098492.
DOI: 10.1371/journal.pntd.0012014.
Human strongyloidiasis: complexities and pathways forward.
Buonfrate D, Bradbury R, Watts M, Bisoffi Z
Clin Microbiol Rev. 2023; 36(4):e0003323.
PMID: 37937980
PMC: 10732074.
DOI: 10.1128/cmr.00033-23.
Biodegradation of the methylenedioxyphenyl group in piperine and its derivatives: discovery of a novel methylenetransferase in an actinomycete.
Jian P, Kumano T, Kimura M, Kurisaki M, Hashimoto Y, Kobayashi M
Appl Environ Microbiol. 2023; 89(11):e0114523.
PMID: 37874289
PMC: 10686052.
DOI: 10.1128/aem.01145-23.
A cross-lingual analysis on the spread of misinformation using the case of Ivermectin as a treatment for Covid-19.
Lai C, Toriumi F, Yoshida M
Sci Rep. 2023; 13(1):14686.
PMID: 37673903
PMC: 10482930.
DOI: 10.1038/s41598-023-41760-8.
Comparative Metabolome Analyses of Ivermectin-Resistant and -Susceptible Strains of .
Tuersong W, Liu X, Wang Y, Wu S, Qin P, Zhu S
Animals (Basel). 2023; 13(3).
PMID: 36766346
PMC: 9913829.
DOI: 10.3390/ani13030456.
Hepatic disorders associated with the use of Ivermectin for SARS-CoV-2 infection in adults: a pharmacovigilance study in VigiBase.
Oscanoa T, Amado J, Romero-Ortuno R, Carvajal A
Gastroenterol Hepatol Bed Bench. 2023; 15(4):426-429.
PMID: 36762224
PMC: 9876768.
DOI: 10.22037/ghfbb.v15i4.2383.
A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective?.
Nabi-Afjadi M, Mohebi F, Zalpoor H, Aziziyan F, Akbari A, Moradi-Sardareh H
Inflammopharmacology. 2023; 31(1):21-35.
PMID: 36609716
PMC: 9823263.
DOI: 10.1007/s10787-022-01129-1.
Ameliorating effect of the biological Zinc nanoparticles in abamectin induced hepato-renal injury in a rat model: Implication of oxidative stress, biochemical markers and COX-2 signaling pathways.
Aioub A, Abdelnour S, Shukry M, Saad A, El-Saadony M, Chen Z
Front Pharmacol. 2022; 13:947303.
PMID: 36172185
PMC: 9510891.
DOI: 10.3389/fphar.2022.947303.
Insecticidal characteristics and structural identification of the potential active compounds from Streptomyces sp. KR0006: Strain improvement through mutagenesis.
Kim Y, Umurzokov M, Cho K, Choi J, Park K
PLoS One. 2022; 17(9):e0274766.
PMID: 36155980
PMC: 9512179.
DOI: 10.1371/journal.pone.0274766.
Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19.
Awad H, Hassan B, Dweek S, Aboelata Y, Rawas-Qalaji M, Ahmed I
Pharmaceuticals (Basel). 2022; 15(9).
PMID: 36145289
PMC: 9506580.
DOI: 10.3390/ph15091068.
Most common inappropriate drug usage factors in anthelmintic treatment on sheep farms in Latvia.
Kovalcuka L, Keidane D, Klavina A, Grasberga M, Veksins A
Vet World. 2022; 15(2):244-251.
PMID: 35400951
PMC: 8980379.
DOI: 10.14202/vetworld.2022.244-251.
Pharmacokinetics and safety of inhaled ivermectin in mice as a potential COVID-19 treatment.
Albariqi A, Wang Y, Chang R, Quan D, Wang X, Kalfas S
Int J Pharm. 2022; 619:121688.
PMID: 35314278
PMC: 8933053.
DOI: 10.1016/j.ijpharm.2022.121688.
Could the COVID-19-Driven Increased Use of Ivermectin Lead to Incidents of Imbalanced Gut Microbiota and Dysbiosis?.
Dicks L, Deane S, Grobbelaar M
Probiotics Antimicrob Proteins. 2022; 14(2):217-223.
PMID: 35218001
PMC: 8881049.
DOI: 10.1007/s12602-022-09925-5.
Decoyinine Induced Resistance in Rice against Small Brown Planthopper .
Shah A, Ma C, Zhang Y, Zhang Q, Xu G, Yang G
Insects. 2022; 13(1).
PMID: 35055947
PMC: 8781946.
DOI: 10.3390/insects13010104.
Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication.
Low Z, Yip A, Lal S
Biochim Biophys Acta Mol Basis Dis. 2021; 1868(2):166294.
PMID: 34687900
PMC: 8526435.
DOI: 10.1016/j.bbadis.2021.166294.
COVID-19 and Ivermectin: Potential threats associated with human use.
Zaheer T, Pal K, Abbas R, Torres M
J Mol Struct. 2021; 1243:130808.
PMID: 34149064
PMC: 8195608.
DOI: 10.1016/j.molstruc.2021.130808.